Karius

Metagenomic blood and lung tests that detect microbes behind hard-to-diagnose infections, sold to hospitals and clinicians in the US

+ Add to sales board

Recent signals

What changed at Karius in the last 6 months, newest first. Each line links to its public source.

  • 22 Oct 2026 Leadership hire · Hiring Director, Marketing Operations & Sales Enablement (Redwood City) jobs.lever.co
  • 16 Oct 2026 Leadership hire · Hiring Regional Sales Director (Western Region) (San Francisco) jobs.lever.co
  • 13 Oct 2026 Leadership hire · Hiring Director, Medical Science Liaison (East) jobs.lever.co

Get signals like these for the companies you sell to →

About Karius

Karius is a clinical metagenomics company that sequences microbial cell-free DNA to detect pathogens behind infections. Its Karius Spectrum is a plasma blood test covering over 1,000 fungi, bacteria, DNA viruses and parasites, and Karius Focus | BAL is a bronchoalveolar lavage test for over 500 lung pathogens. The company uses its Karius HelionTM platform, a proprietary reference database and AI-based analysis.

Customers are hospitals, transplant centers and healthcare providers in the US, and biopharma partners for clinical development. Revenue comes from ordering its laboratory tests; the website states over 600 hospitals and transplant centers use its testing and that over 100,000 patient samples have been tested. A collaboration with Mayo Clinic Laboratories makes its tests orderable there.

Karius was founded in 2014, is built on intellectual property developed at Stanford University, and is headquartered in Redwood City, California. It operates a CLIA-certified, CAP-accredited and ISO 15189-accredited laboratory. Its open roles are mainly commercial and clinical sales positions across US regions, plus laboratory, clinical research, software engineering and marketing operations.

Product: Karius Spectrum blood test and Karius Focus | BAL lung test, metagenomic sequencing of microbial cell-free DNA for infectious disease diagnosis.

Jobs at Karius

No open positions in Europe right now.

Open roles at Karius in the Americas (16)

United States 16. From Karius's careers page or applicant tracking system; each role links to the employer.

Newest 12 of 16.

Leadership

More health & medtech companies

  • Kestra Medical Technologies

    Wearable defibrillator and cloud patient-monitoring platform for at-risk cardiac patients and their care teams
    United StatesHealth & medtech
  • Kidneymn

    Physician-owned nephrology practice providing kidney disease, dialysis and transplant care in Minnesota and western Wisconsin
    United StatesHealth & medtech
    New on Evolc
  • Kontakt.io

    RTLS and AI care operations platform for hospitals: asset tracking, staff safety and patient-flow management
    United StatesHealth & medtech
  • Lakefield Veterinary Group

    Acquires veterinary practices and supports hospital teams while preserving their independence and local identity
    United StatesHealth & medtech
  • Legion Health

    Virtual psychiatric care and medication management for people seeking treatment for mental health conditions
    United StatesHealth & medtech
  • LightForce Orthodontics

    3D-printed patient-specific orthodontic braces and indirect bonding trays for orthodontic practices in the US
    United StatesHealth & medtech2 open jobs
    Remote-friendly

All health & medtech companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content management

  • SanityHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • Next.jsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • ReactMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.